Redox modifier genes and pathways in amyotrophic lateral sclerosis

Area of Science:

• Neuroscience
• Cell Biology
• Genetics

Background:

• Neuroinflammation and enhanced redox-stress are implicated in amyotrophic lateral sclerosis (ALS) progression.
• The precise role of reactive oxygen species (ROS) metabolism versus neuroinflammation in ALS pathogenesis remains debated.
• Growing evidence links genetic defects in NADPH oxidases to certain forms of ALS.

Purpose of the Study:

• To explore the role of NADPH oxidases in cellular signaling and their connection to ALS.
• To provide a framework for understanding endosomal signaling mediated by NADPH oxidases in ALS.
• To review current and past antioxidant therapies for ALS.

Main Methods:

• Literature review focusing on NADPH oxidase function, cell signaling, and ALS genetics.
• Analysis of mechanisms linking NADPH oxidase gene defects to neuroinflammation and motor neuron degeneration.
• Synthesis of information on antioxidant treatment strategies for ALS.

Main Results:

• NADPH oxidases are critical signaling complexes affecting cellular responses to cytokines and growth factors.
• NADPH oxidase-derived ROS can spatially regulate redox-dependent pro-inflammatory receptor activation.
• Gene defects in NADPH oxidases may lead to dysregulated pro-inflammatory signaling and motor neuron degeneration in ALS.

Conclusions:

• Understanding NADPH oxidase-mediated endosomal signaling is key to clarifying ALS pathogenesis.
• Genetic factors influencing NADPH oxidases offer potential insights into ALS mechanisms.
• Antioxidant therapies for ALS have shown varied success, highlighting the need for targeted approaches.